CTOs on the Move

QurAlis

www.quralis.com

 
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.quralis.com
  • 100 Cambridgepark Drive 5th Floor
    Cambridge, MA USA 02140
  • Phone: 781.816.7031

Executives

Name Title Contact Details

Funding

QurAlis raised $42M on 05/13/2020

Similar Companies

Terumo Heart

Terumo Heart, Inc. is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Loyal

Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too. By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species. At Loyal, our first products to market are focused on longevity and healthspan in dogs. Join us in our mission to help dogs everywhere.

Puerto Rico Ice Technologies Inc

Puerto Rico Ice Technologies Inc is a San Juan, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Axsome

Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of CNS disorders. Axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. The company is based in New York City.

ProZyme

ProZyme is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.